Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate ...Middle East

PR Newswire - News

SAN FRANCISCO and SUZHOU, China, Jan. 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic,...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate )

    Apple Storegoogle play

    Also on site :

    Most viewed in News